SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2009.
Commission File Number: 333-08704
ICON plc
(Translation of registrant's name into English)
South County Business Park, Leopardstown, Dublin 18, Ireland
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ x ] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ]
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ]
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes [ ] No [ x ]
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): .
On April 28, 2009 the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
(c) Exhibit 99.1. Press release dated April 28, 2009
SIGNATURES
Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| ICON plc (Registrant) |
||
| Date: April 29, 2009 | /s/ CIARAN MURRAY Ciaran Murray Chief Financial Officer |
EXHIBIT 99.1
ICON Reports 9% Increase in Revenue, 25% Increase in EPS and Acquisition of a U.S. Phase I Facility
Highlights - First Quarter Fiscal 2009 * First quarter net revenues increased 9% over the comparative quarter, to $219.8 million. * Income from operations increased by 25%, to $26.9 million. * Operating margins expanded to 12.2% from 10.7% * Diluted earnings per share increased by 25%, to 35 cents. * Net new business wins in the quarter of $265m, representing a book-to-bill ratio of 1.2. * Acquired a 100 bed Phase I unit in Omaha, Nebraska.
DUBLIN, Ireland, April 28, 2009 (GLOBE NEWSWIRE) -- ICON (Nasdaq:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter ended March 31, 2009.
Net revenues for the quarter were $219.8 million, representing a 9.2% increase over net revenues of $201.3 million for the comparative quarter last year.
Income from operations was $26.9 million or 12.2% of revenue, compared to $21.5 million or 10.7% for the same quarter last year. Net income was $20.9 million or 35 cents per share on a diluted basis, compared with $16.9 million or 28 cents per share last year.
Days sales outstanding, comprising accounts receivable and unbilled revenue less payments on account, were 59 days at March 31, 2009, compared to 69 days at December 31, 2008.
For the quarter ended March 31, 2009, cash provided from operating activities was $24.7 million and capital expenditure was $8.1 million. As a result, the company's net debt, amounted to $2.2 million at March 31, 2009, compared to net debt of $4.3 million at December 31, 2008.
"The last quarter represented a solid start to 2009," commented Chairman Dr. John Climax. "Revenue was 9% ahead of prior year and earnings per share were up 25%."
"In a much more difficult market, we are pleased with the results for the quarter," said CEO Peter Gray. "Further margin expansion, despite some challenges, led to an overall increase in operating income of 25% compared to the same period last year. Business activity, which was slow to develop early in the quarter, finished strongly to deliver solid net business wins of $265 million and a book to bill of 1.2.
"Demonstrating our confidence in the long term health of the market, on April 20th we acquired the assets of the former Qualia Clinical Services, a Phase I facility based in Omaha, Nebraska, and intend to reopen the unit in May. This investment is expected to be moderately dilutive to 2009 earnings (approx 4 - 6c). Excluding this, we continue to expect to achieve the 2009 guidance given in January, albeit at the lower end."
The company will hold its first quarter conference call today, April 28, 2009 at 9:00 EDT (14:00 Ireland & UK). This call and linked slide presentation can be accessed live from our website at http://www.iconplc.com. A recording will also be available on the website for 90 days following the call. In addition, a calendar of company events, including upcoming conference presentations, is available on our website, under "Investors". This calendar will be updated regularly.
The statements made in this Press Release may contain forward-looking statements that involve a number of risks and uncertainties. In addition to the matters described in this Press Release, the ability to maintain large client contracts or enter into new contracts, maintain client relationships and the ability to manage the opening of new offices, the integration of new business mergers and acquisitions, as well as other risks and uncertainties detailed from time to time in SEC reports filed by ICON, including its Form 20-F, F-1, S-8 and F-3, may affect the actual results achieved by ICON. ICON disclaims any intent or obligation to update these forward-looking statements.
The financial information presented herein has been prepared in accordance with U.S. GAAP.
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development -- from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 71 locations in 38 countries and has approximately 7,100 employees. Further information is available at www.iconplc.com.
ICON/ICLR-F
ICON plc
Consolidated Income Statements (Unaudited)
Three Months ended March 31, 2009 and March 31, 2008
(Dollars, in thousands, except share and per share data)
Three Months Ended
March 31, March 31,
2009 2008
Gross Revenue 318,538 283,853
Reimbursable expenses 98,707 82,509
---------- ----------
Net Revenue 219,831 201,344
Costs and expenses
Direct costs 124,168 113,189
Selling, general and administrative 61,258 60,545
Depreciation and amortization 7,490 6,098
---------- ----------
Total costs and expenses 192,916 179,832
Income from operations 26,915 21,512
Net interest expense (736) (43)
---------- ----------
Income before provision for income taxes 26,179 21,469
Provision for income taxes 5,235 4,247
Minority interest -- 328
---------- ----------
Net income 20,944 16,894
========== ==========
Net income per ordinary share
Basic $ 0.36 $ 0.29
---------- ----------
Diluted $ 0.35 $ 0.28
---------- ----------
Weighted average number of ordinary shares
Basic 58,537,795 57,805,260
Diluted 59,771,335 60,079,472
ICON plc
Summary Balance Sheet Data
March 31, 2009 and December 31, 2008
(Dollars, in thousands)
March 31, December 31,
2009 2008
(Unaudited) (audited)
Cash and short-term investments 96,998 101,104
Debt (99,211) 105,379
Net debt (2,213) (4,275)
Accounts receivable 222,564 210,535
Unbilled revenue 122,757 141,727
Payments on account (134,989) (121,935)
Total 210,332 230,327
Working Capital 209,099 185,957
Total Assets 850,536 867,285
Shareholders' Equity 474,391 456,366
CONTACT: ICON plc
Investor Relations
1-888-381-7923
Ciaran Murray, CFO
+ 353-1-291-2000